Home › Funds › Balyasny Asset Management › CLOV
Balyasny Asset Management position in CLOV
CLOVER HEALTH INVESTMENTS CO · Health Care
Latest position (Q1 2026)116.25K sh
Reported value held$204.61K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 182.85K | $1.35M | New |
| Q4 2021 | 170.03K | $633.00K | Reduce |
| Q3 2022 | 211.11K | $359.00K | New |
| Q4 2022 | 40.18K | $37.35K | Reduce |
| Q1 2023 | 579.19K | $489.47K | Add |
| Q4 2023 | 59.97K | $57.10K | New |
| Q3 2024 | 86.82K | $244.83K | New |
| Q4 2024 | 438.06K | $1.38M | Add |
| Q1 2025 | 395.37K | $1.42M | Reduce |
| Q3 2025 | 182.22K | $557.58K | New |
| Q1 2026 | 116.25K | $204.61K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CLOV
- BlackRock Inc 35.11M sh · $183.96M · Q2 2026
- Geode Capital Management 10.85M sh · $56.84M · Q2 2026
- Vanguard Group 23.49M sh · $55.19M · Q4 2025
- Charles Schwab Investment Management 5.52M sh · $28.93M · Q2 2026
- Northern Trust Corp 3.77M sh · $19.77M · Q2 2026
- PNC Financial Services 3.56M sh · $18.67M · Q2 2026
- Renaissance Technologies 2.81M sh · $14.71M · Q2 2026
- Morgan Stanley 2.29M sh · $12.02M · Q2 2026
- D. E. Shaw & Co 1.97M sh · $10.30M · Q2 2026
- Marshall Wace 1.56M sh · $8.19M · Q2 2026
- Invesco Ltd 1.34M sh · $7.00M · Q2 2026
- BNY Mellon 1.21M sh · $6.35M · Q2 2026